Siren »

Vigil Neuroscience shares owned by Siren

Quarter-by-quarter ownership of Vigil Neuroscience (VIGL) shares owned by Siren from 13F filings

Historical chart of Siren investment in Vigil Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Vigil Neuroscience held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vigil Neuroscience by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.8M 2.0M 3.40

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics (BCAX)
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Vigil Neuroscience

Atlas Venture Life Science Advisors
Northpond Ventures
Siren
BVF
Deep Track Capital
Citadel Advisors
Sphera Funds Management
683 Capital Management
Vanguard Group
Stempoint Capital
Ensign Peak Advisors
Pivotal bioVenture Partners Investment Advisor
Standard Life Aberdeen
Ikarian Capital
Woodline Partners

View all funds holding Vigil Neuroscience